158 related articles for article (PubMed ID: 19697618)
1. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions.
Guida M; Sanguedolce F; Bufo P; Di Spiezio Sardo A; Bifulco G; Nappi C; Pannone G
Eur J Gynaecol Oncol; 2009; 30(3):267-70. PubMed ID: 19697618
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization.
Di Domenico M; Santoro A; Ricciardi C; Iaccarino M; Iaccarino S; Freda M; Feola A; Sanguedolce F; Losito S; Pasquali D; Di Spiezio Sardo A; Bifulco G; Nappi C; Bufo P; Guida M; De Rosa G; Abbruzzese A; Caraglia M; Pannone G
Cancer Biol Ther; 2011 Sep; 12(5):447-57. PubMed ID: 21709441
[TBL] [Abstract][Full Text] [Related]
3. Gene Promoter Methylation in Endometrial Carcinogenesis.
Cornel KMC; Wouters K; Van de Vijver KK; van der Wurff AAM; van Engeland M; Kruitwagen RFPM; Pijnenborg JMA
Pathol Oncol Res; 2019 Apr; 25(2):659-667. PubMed ID: 30430425
[TBL] [Abstract][Full Text] [Related]
4. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
[TBL] [Abstract][Full Text] [Related]
6. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
Wang F; Xie XJ; Piao YS; Liu B; Wang LD
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis.
Martini M; Ciccarone M; Garganese G; Maggiore C; Evangelista A; Rahimi S; Zannoni G; Vittori G; Larocca LM
Int J Cancer; 2002 Dec; 102(4):398-406. PubMed ID: 12402310
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
9. CpG island methylation in premalignant stages of gastric carcinoma.
Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
[TBL] [Abstract][Full Text] [Related]
10. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.
Esteller M; Catasus L; Matias-Guiu X; Mutter GL; Prat J; Baylin SB; Herman JG
Am J Pathol; 1999 Nov; 155(5):1767-72. PubMed ID: 10550333
[TBL] [Abstract][Full Text] [Related]
11. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
12. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
Geddert H; Zur Hausen A; Gabbert HE; Sarbia M
Anal Cell Pathol (Amst); 2010; 33(3):143-9. PubMed ID: 20978327
[TBL] [Abstract][Full Text] [Related]
13. hMLH1 promoter methylation status causes different expression patterns of estrogen receptor protein with endometrial lesion progression.
Nishijima Y; Yoshida T; Nakamura K; Fukuda T
Rinsho Byori; 2013 Feb; 61(2):97-103. PubMed ID: 23672086
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
[TBL] [Abstract][Full Text] [Related]
15. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
[TBL] [Abstract][Full Text] [Related]
16. Association between p16, hMLH1 and E-cadherin promoter hypermethylation and intake of local hot salted tea and sun-dried foods in Kashmiris with gastric tumors.
Mir MR; Shabir N; Wani KA; Shaff S; Hussain I; Banday MA; Chikan NA; Bilal S; Aejaz S
Asian Pac J Cancer Prev; 2012; 13(1):181-6. PubMed ID: 22502664
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
Viswanathan M; Tsuchida N; Shanmugam G
Int J Cancer; 2003 May; 105(1):41-6. PubMed ID: 12672028
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
[TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
Puri SK; Si L; Fan CY; Hanna E
Am J Otolaryngol; 2005; 26(1):12-7. PubMed ID: 15635575
[TBL] [Abstract][Full Text] [Related]
20. [Methylation and expression of the p16 gene in endometrial carcinoma].
Chao H; Sun J; Lu S
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):228-31. PubMed ID: 11778238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
